Organon USA (Roseland, NJ) recently announced the availability of a 900-international unit (IU) presentation of Follistim AQ Cartridge for use with the Follistim Pen. The Follistim AQ Cartridge is the first follicle-stimulating hormone treatment available in a prefilled, premixed solution approved in the United States. The product eliminates the need for patients to mix 1 or more vials of medication. The Follistim AQ Cartridge is indicated for the development of multiple follicles in ovulatory patients participating in an assisted reproductive technology program. In addition, it is indicated for the induction of ovulation and pregnancy in anovulatory infertile patients in whom the cause of infertility is functional and not due to primary ovarian failure. The product also is available in 300-and 600-IU presentations. For more information, visit www.follistim.com, or call 800-241-8812.
Although the annual HIV diagnosis rate between 2010 and 2014 decreased for black individuals by 16.2%, blacks remain disproportionately affected by HIV/AIDS.
Clinical features with downloadable PDFs